Pharma industry reports deals worth $18.6 billion in May 2022: GlobalData
The pharma industry reported 78 deals worth $18.6 billion as compared to the last 12-month average (May 2021 to April 2022) of 82…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
P&G Health partners with Lakshya and Recycle India Foundation to promote sustainable pharmacy…
The initiative aims to promote sustainable healthcare practices through an on-ground awareness campaign for pharmacy owners and…
11th Annual InnoPack Pharma Confex to be held in Mumbai
The show will offer exhibition floor, semi-scientific conferences and a spotlight for innovations allowing the pharma packaging…
Cipla adds capacity of captive renewable energy power plant in Maharashtra and Karnataka
The project will support the company’s green energy requirements for its manufacturing units at Kurkumbh and Patalganga and…
New Novartis data show Piqray effectiveness across key biomarkers in patients with HR+/HER2-…
Biomarker analysis from phase-III Solar-1 study shows Piqray plus fulvestrant had clinical benefit regardless of presence of ESR1…
US FDA flags risk of heart inflammation after Novavax COVID vaccine
In Novavax's nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of a type of…
Sun Pharma to expand field force in India by 10 per cent this fiscal
The company currently employs around 11,000 Medical Representatives (MRs) and related staff in the country
Corbevax gets DCGI nod as heterologous COVID-19 booster dose
It is the first vaccine in India to get DCGI approval for a heterologous COVID-19 booster shot
Zydus Lifesciences receives final approval from US FDA for Famotidine tablets
Famotidine is a histamine H2 receptor blocker
Myovant Sciences and Pfizer announce US FDA acceptance of supplemental NDA for Myfembree
The US FDA set a target action date of 29th January, 2023 for this sNDA under the Prescription Drug User Fee Act (PDUFA)